Micro
Aftermath
Active
诺和制药公司较高剂量Wegovy获得FDA批准
Activity declining — narrative losing relevance.
评分
0.3
动能
▲ 0.0
文章
14
来源
3
Sentiment Timeline
Event Timeline
四月 02, 2026
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
Bullish
四月 01, 2026
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
Bullish
三月 31, 2026
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries …
Neutral
相关文章
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
Nasdaq
·
四月 01, 2026
Could This New Approval Be a Turning Point For Novo Nordisk?
Nasdaq
·
四月 01, 2026
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to …
CNBC
·
三月 23, 2026
This Hims & Hers Move Could Destroy Competitors
Nasdaq
·
三月 21, 2026
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?
Nasdaq
·
三月 20, 2026
Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss drugs.
Yahoo Finance
·
三月 20, 2026
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to …
CNBC
·
三月 19, 2026
时间线
首次发现三月 19, 2026
最后更新三月 19, 2026